Inflammatory Breast Cancer: What surgeons need to know.

• Published in: European Journal of Surgical Oncology
• Main Authors: Rafnsdóttir, Svanheiður Lóa, Audisio, Riccardo A
• Other Authors: 1 Oncoplastic Breast Surgery, Department of Surgery, Landspitali University Hospital, 13-A Hringbraut, IS-101, Reykjavik, Iceland; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Blå Stråket 5, 413 45, Göteborg, Sweden. Electronic address: [e-mail]. 2 Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Blå Stråket 5, 413 45, Göteborg, Sweden. Electronic address: [e-mail].
• Format: Article in Journal/Newspaper
• Language: English
• Published: Elsevier 2018
• Subjects: Brjóstakrabbamein; Skurðlækningar; Skurðlæknar; Breast Neoplasms; Inflammatory Breast Neoplasms; Surgeons; Iceland
• Online Access: http://hdl.handle.net/2336/620673; https://doi.org/10.1016/j.ejso.2018.06.007

To access publisher's full text version of this article click on the hyperlink below Strict criteria to identify Inflammatory Breast Cancer (IBC) have been made available - these are based on pathological as well as clinical observations. It is mandatory to confirm the criteria used in any further report. Scientific evidence accumulated so far is confusing, and unclear therefore no hard conclusion can be drawn from the available literature on the management of IBC. The advent of new medications results into an up-to-date management and different outcomes. It is mandatory to follow these criteria if reliable guidelines are to be made available in the next future. 1 ] Landspitali Univ Hosp, Dept Surg, Oncoplast Breast Surg, 13-A Hringbraut, IS-101 Reykjavik, Iceland Show more [ 2 ] Sahlgrens Univ Hosp, Inst Clin Sci, Dept Surg, Bla Straket 5, S-41345 Gothenburg, Sweden